Pays: Canada
Langue: anglais
Source: Health Canada
VASOPRESSIN
SANDOZ CANADA INCORPORATED
H01BA01
VASOPRESSIN (ARGIPRESSIN)
20UNIT
SOLUTION
VASOPRESSIN 20UNIT
INTRAMUSCULAR
2/5ML
Prescription
PITUITARY
Active ingredient group (AIG) number: 0106469001; AHFS:
APPROVED
2005-08-19
PRESCRIBING INFORMATION PR VASOPRESSIN INJECTION USP Sterile Solution; 20 USP pressor units / mL For Intramuscular (IM) or Subcutaneous (SC) Injection Antidiuretic Agent Sandoz Canada Inc. Date of Revision: August 26, 2020 110 Rue De Lauzon Boucherville Quebec Canada J4B 1E6 Control No.: 216180 Vasopressin Injection USP Page 2 of 5 VASOPRESSIN INJECTION USP 20 USP pressor units / mL Sterile THERAPEUTIC CLASSIFICATION Antidiuretic Agent PHARMACOLOGY Vasopressin Injection USP is a synthetic water-soluble pressor principle identical in sequence to arginine vasopressin. Vasopressin exerts its antidiuretic action by increasing the reabsorption of water by the renal tubules. The drug also can cause contraction of smooth muscle of the gastrointestinal tract and of all parts of the vascular beds, especially the capillaries, small arterioles, and venules, with less effect on the smooth musculature of the large veins. The direct effect on the contractile elements is neither antagonized by adrenergic blocking agents nor prevented by vascular denervation. Vasopressin Injection USP is intended for intramuscular (IM) or subcutaneous (SC) injection. INDICATIONS AND CLINICAL USE Vasopressin Injection USP is intended for use in the prevention or treatment of post-operation abdominal distention, dispelling of gas shadows in abdominal roentgenography and symptomatic control of diabetes insipidus. CONTRAINDICATIONS Vasopressin Injection USP should not be used in patients having cardiorenal disease with hypertension, advanced arteriosclerosis, coronary thrombosis, angina pectoris, epilepsy or toxemia of pregnancy. Anaphylaxis or hypersensitivity to the drug or its components are also contraindications. Chronic nephritis with nitrogen retention may be a contraindication (see PRECAUTIONS). WARNINGS Vasopressin Injection USP should not be used except with extreme caution in patients with Vasopressin Injection USP Page 3 of 5 vascular disease, especially disease of the coronary arteries. In such patients even small doses of the drug may Lire le document complet